18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
N-3 polyunsaturated fatty acids (PUFAs) have potential cardiovascular benefit, although the mechanisms underlying this effect remain poorly understood. Fat-1 transgenic mice expressing Caenorhabditis elegans n-3 fatty acid desaturase, which is capable of producing n-3 PUFAs from n-6 PUFAs, exhibited resistance to pressure overload–induced inflammation and fibrosis, as well as reduced cardiac function. Lipidomic analysis revealed selective enrichment of eicosapentaenoic acid (EPA) in fat-1 transgenic bone marrow (BM) cells and EPA-metabolite 18-hydroxyeicosapentaenoic acid (18-HEPE) in fat-1 transgenic macrophages. BM transplantation experiments revealed that fat-1 transgenic BM cells, but not fat-1 transgenic cardiac cells, contributed to the antiremodeling effect and that the 18-HEPE–rich milieu in the fat-1 transgenic heart was generated by BM-derived cells, most likely macrophages. 18-HEPE inhibited macrophage-mediated proinflammatory activation of cardiac fibroblasts in culture, and in vivo administration of 18-HEPE reproduced the fat-1 mice phenotype, including resistance to pressure overload–induced maladaptive cardiac remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · cited 1×
“Lipids were extracted by the method of Bligh and Dyer (Bligh and Dyer, 1959).”
MethodMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 1×
“Sustained pressure overload elicits cardiomyocyte hypertrophy, inflammatory cell infiltration, and fibrosis, thereby changing LV stiffness and geometry (Wynn and Ramalingam, 2012; Weber et al., 2013).”
BackgroundYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · cited 1×
“In culture, n-3 fatty acids at 100 µM reportedly stimulate GPR120 production and mediate anti-inflammatory effects (Oh et al., 2010), whereas again here, we demonstrated a maximal such effect with 18-HEPE at 10 nM.”
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300 · cited 3×
“Because both Ccl2 (MCP-1) mRNA levels and Cx3cl1 (Fractalkine) mRNA levels were suppressed in fat-1 transgenic hearts, we speculate that the sequential recruitment of monocyte subsets was attenuated in fat-1 transgenic hearts.”
BackgroundOmega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771
Epelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Controversies in ventricular remodelling
Opie, L. H., Commerford, P. J., Gersh, B. J., & Pfeffer, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68074-4 · Cited by 861 · cited 1×
“Increased cardiac afterload caused by hypertension, aortic valve stenosis, or natural aging is responsible for the pathogenesis and progression of heart failure accompanied by common histological changes, the so-called maladaptive cardiac remodeling (Opie et al., 2006).”
BackgroundMyofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 673 · cited 1×
“Sustained pressure overload elicits cardiomyocyte hypertrophy, inflammatory cell infiltration, and fibrosis, thereby changing LV stiffness and geometry (Wynn and Ramalingam, 2012; Weber et al., 2013).”
BackgroundFat-1 mice convert n-6 to n-3 fatty acids
Kang, J. X., Wang, J., Wu, L., & Kang, Z. B. (2004) · Nature · doi:10.1038/427504a · Cited by 545 · cited 1×
“Recently, Kang et al. (2004) developed a transgenic mouse expressing the C. elegans fat-1 gene encoding n-3 desaturase, which converts n-6 to n-3 PUFAs.”
BackgroundSelf-citationLeuschner, F., Rauch, P. J., Ueno, T., Gorbatov, R., Marinelli, B., Lee, W. W., Dutta, P., Wei, Y., Robbins, C., Iwamoto, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111009 · Cited by 521
Meléndez, G. C., McLarty, J. L., Levick, S. P., Du, Y., Janicki, J. S., & Brower, G. L. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148635 · Cited by 442
Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis
Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., Dignass, A., Serhan, C. N., & Kang, J. X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601280103 · Cited by 379 · cited 1×
“…show enrichment of n-3 PUFAs in almost all organs and tissues, and display a resistant phenotype against inflammatory diseases including colitis (Hudert et al., 2006), pancreatitis (Weylandt et al., 2008), osteoarthritis (Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-sity-linked…”
BackgroundSelf-citationFatty Acids as Modulators of the Immune Response
Fritsche, K. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092610 · Cited by 316 · cited 1×
“…PUFAs have potential anti-inflammatory activity in a variety of inflammatory diseases, including atherosclerosis, diabetes, asthma and arthritis (Fritsche, 2006; Zhang and Spite, 2012). activation upon pressure overload than WT mice, leading to preservation of %FS. Myofibroblast activation by…”
BackgroundHypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation?
Kuwahara, F., Kai, H., Tokuda, K., Takeya, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2004) · Hypertension · doi:10.1161/01.hyp.0000118584.33350.7d · Cited by 282 · cited 3×
“Cardiac fibroblasts can be activated directly by pressure overload or secondarily by inflammatory mediators released from activated inflammatory cells (Nicoletti et al., 1996; Koyanagi et al., 2000; Kuwahara et al., 2004; Kai et al., 2006).”
BackgroundMa, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., Qi, Y., & Du, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035144 · Cited by 271
Sano, M., Fukuda, K., Kodama, H., Pan, J., Saito, M., Matsuzaki, J., Takahashi, T., Makino, S., Kato, T., & Ogawa, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003128200 · Cited by 233
Self-citationNodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Dei Cas, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.017 · Cited by 217 · cited 1×
“…heart failure who were receiving standard treatment (Tavazzi et al., 2008), and ameliorated left ventricular (LV) functional capacity and decreased the circulating concentrations of inflammatory cytokines such as TNF, IL-1 , and IL-6 in nonischemic dilated cardiomyopathy (Nodari et al., 2011).”
BackgroundWhite, P. J., Arita, M., Taguchi, R., Kang, J. X., & Marette, A. (2010) · Diabetes · doi:10.2337/db10-0054 · Cited by 185 · cited 1×
“…inflammatory diseases including colitis (Hudert et al., 2006), pancreatitis (Weylandt et al., 2008), osteoarthritis (Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-sity-linked insulin resistance (White et al., 2010), and some kinds of cancer (Xia et al., 2006; Weylandt et al., 2011).”
BackgroundSelf-citationCardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure
Kayama, Y., Minamino, T., Toko, H., Sakamoto, M., Shimizu, I., Takahashi, H., Okada, S., Tateno, K., Moriya, J., Yokoyama, M., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082596 · Cited by 173 · cited 1×
“Activated cardiac fibroblasts produce proinflammatory cytokines and chemokines, such as IL-6 and MCP-1, facilitating macrophage activation (Koyanagi et al., 2000; Sano et al., 2000; Kuwahara et al., 2004; Kayama et al., 2009; Meléndez et al., 2010; Ma et al., 2012).”
BackgroundZhang, M. J., & Spite, M. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150726 · Cited by 171 · cited 1×
“…anti-inflammatory activity in a variety of inflammatory diseases, including atherosclerosis, diabetes, asthma and arthritis (Fritsche, 2006; Zhang and Spite, 2012). activation upon pressure overload than WT mice, leading to preservation of %FS. Myofibroblast activation by pressure overload…”
BackgroundChen, J., Shearer, G. C., Chen, Q., Healy, C. L., Beyer, A. J., Nareddy, V. B., Gerdes, A. M., Harris, W. S., O'Connell, T. D., & Wang, D. (2011) · Circulation · doi:10.1161/circulationaha.110.971853 · Cited by 163 · cited 2×
“Real-time PCR was performed using the SYBR Premix Ex Taq kit (Takara) (Duda et al., 2007; Chen et al., 2011).”
MethodWeylandt, K. H., Krause, L. F., Gomolka, B., Chiu, C.-Y., Bilal, S., Nadolny, A., Waechter, S. F., Fischer, A., Rothe, M., & Kang, J. X. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr049 · Cited by 142 · cited 1×
“…inflammatory diseases including colitis (Hudert et al., 2006), pancreatitis (Weylandt et al., 2008), osteoarthritis (Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-sity-linked insulin resistance (White et al., 2010), and some kinds of cancer (Xia et al., 2006; Weylandt et al., 2011).”
BackgroundSelf-citationMelanoma growth is reduced in fat-1 transgenic mice: Impact of omega-6/omega-3 essential fatty acids
Xia, S., Lü, Y., Wang, J., He, C., Hong, S., Serhan, C. N., & Kang, J. X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605394103 · Cited by 142 · cited 1×
“…inflammatory diseases including colitis (Hudert et al., 2006), pancreatitis (Weylandt et al., 2008), osteoarthritis (Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-sity-linked insulin resistance (White et al., 2010), and some kinds of cancer (Xia et al., 2006; Weylandt et al., 2011).”
BackgroundSelf-citationMediator lipidomics in acute inflammation and resolution
Arita, M. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs092 · Cited by 131 · cited 1×
“LC-MS/MS–based lipidomics analyses were performed using a high-performance liquid chromatography (HPLC) system (Waters UPLC) with a linear ion-trap quadrupole mass spectrometer (QTRAP5500; AB SCIEX) equipped with an Acquity UPLC BEH C 18 column (Waters) as described previously (Arita, 2012).”
MethodSelf-citationKAI, H., MORI, T., TOKUDA, K., TAKAYAMA, N., TAHARA, N., TAKEMIYA, K., KUDO, H., SUGI, Y., FUKUI, D., YASUKAWA, H., et al. (2006) · Hypertension Research · doi:10.1291/hypres.29.711 · Cited by 114
Wan, J.-B., Huang, L.-L., Rong, R., Tan, R., Wang, J., & Kang, J. X. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.210054 · Cited by 109
Self-citationDUDA, M., OSHEA, K., LEI, B., BARROWS, B., AZIMZADEH, A., MCELFRESH, T., HOIT, B., KOP, W., & STANLEY, W. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.002 · Cited by 108
Koyanagi, M., Egashira, K., Kitamoto, S., Ni, W., Shimokawa, H., Takeya, M., Yoshimura, T., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.18.2243 · Cited by 102 · cited 3×
“Cardiac fibroblasts can be activated directly by pressure overload or secondarily by inflammatory mediators released from activated inflammatory cells (Nicoletti et al., 1996; Koyanagi et al., 2000; Kuwahara et al., 2004; Kai et al., 2006).”
BackgroundWeylandt, K. H., Nadolny, A., Kahlke, L., Köhnke, T., Schmöcker, C., Wang, J., Lauwers, G. Y., Glickman, J. N., & Kang, J. X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.011 · Cited by 79 · cited 1×
“…all organs and tissues, and display a resistant phenotype against inflammatory diseases including colitis (Hudert et al., 2006), pancreatitis (Weylandt et al., 2008), osteoarthritis (Huang et al., 2012), atherosclerosis (Wan et al., 2010), obe-sity-linked insulin resistance (White et al.,…”
BackgroundSelf-citationTotal Synthesis and Bioactivity of Resolvin E2
Ogawa, S., Urabe, D., Yokokura, Y., Arai, H., Arita, M., & Inoue, M. (2009) · Organic Letters · doi:10.1021/ol901350g · Cited by 78 · cited 1×
“RvE2 and RvE3 were chemically synthesized as described previously (Ogawa et al., 2009; Isobe et al., 2013).”
MethodSelf-citationStereochemical assignment and anti-inflammatory properties of the omega-3 lipid mediator resolvin E3
Isobe, Y., Arita, M., Iwamoto, R., Urabe, D., Todoroki, H., Masuda, K., Inoue, M., & Arai, H. (2013) · Journal of Biochemistry · doi:10.1093/jb/mvs151 · Cited by 66 · cited 1×
“RvE2 and RvE3 were chemically synthesized as described previously (Ogawa et al., 2009; Isobe et al., 2013).”
MethodSelf-citationEndo, J., Sano, M., Fujita, J., Hayashida, K., Yuasa, S., Aoyama, N., Takehara, Y., Kato, O., Makino, S., Ogawa, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.650903 · Cited by 56
Self-citationIntra-articular lentivirus-mediated insertion of the fat-1 gene ameliorates osteoarthritis
Huang, M., Wang, L., Zheng, X., Zhang, Z., Yan, B., Chen, T.-Y., Bai, X., & Jin, D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.07.035 · Cited by 6
Cited by
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs
Gabbs, M., Leng, S., Devassy, J. G., Monirujjaman, M., & Aukema, H. M. (2015) · Advances in Nutrition · doi:10.3945/an.114.007732 · Cited by 798
Mechanisms of Organ Injury and Repair by Macrophages
Vannella, K. M., & Wynn, T. A. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034356 · Cited by 656
Layé, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014092 · Cited by 420
“7 mg/d) leads to increased blood level of 18-HEPE, with no effect on RvE2 and 3 (Endo et al., 2014).”
BackgroundInfluentialCardioprotective mechanism of omega-3 polyunsaturated fatty acids
Endo, J., & Arita, M. (2016) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.08.002 · Cited by 369
Self-citation
Metadata
- Authors
- Endo, J., Sano, M., Isobe, Y., Fukuda, K., Kang, J. X., Arai, H., & Arita, M.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-07-21
- Volume
- 211
- Issue
- 8
- Pages
- 1673-1687
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2079501596
- Cited by
- 170
- References
- 35
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.